Fund Holdings — Artia Global Partners LP

Total Portfolio Value:
$568.34M
Total Bought:
$170.00M
Total Sold:
$83.05M
Net Transaction:
+$86.95M
Notable People:
Onusa Nmn Chantanapongwanij, Artia Global Partners Gp Llc
Securities
▲▼
SharesValue
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Insmed Incorporated(INSM)752,712732,212-20,500$75.75M$105.45M18.55%+$29.69M
argenx SEADR(ARGX)78,31178,3110$43.17M$57.76M10.16%+$14.59M
Soleno Therapeutics Inc494,424672,176+177,752$41.42M$45.44M8.00%+$4.02M
Verona Pharma PlcADS924,204379,004-545,200$87.41M$40.44M7.12%-$46.97M
uniQure N.V.SHS(QURE)0658,839+658,839$0$38.46M6.77%+$38.46M
Merus N V296,750296,7500$15.61M$27.94M4.92%+$12.33M
ProShares Ultra SilverULTRA GOLD(AGQ)0537,372+537,372$0$24.75M4.36%+$24.75M
Eli Lilly and Company(LLY)30,70028,700-2,000$23.93M$21.90M3.85%-$2.03M
Vertex Pharmaceuticals Incorporated(VRTX)4,40055,100+50,700$1.96M$21.58M3.80%+$19.62M
ABIVAX Société AnonymeADS(ABVX)0225,453+225,453$0$19.14M3.37%+$19.14M
Trevi Therapeutics, Inc.(TRVI)1,311,8401,999,702+687,862$7.18M$18.30M3.22%+$11.12M
Boston Scientific Corporation(BSX)155,200183,200+28,000$16.67M$17.89M3.15%+$1.22M
Alnylam Pharmaceuticals, Inc.(ALNY)20,97034,570+13,600$6.84M$15.76M2.77%+$8.93M
Quest Diagnostics Incorporated(DGX)81,71781,7170$14.68M$15.57M2.74%+$894.8K
AstraZeneca PLCADR(AZN)190,752190,7520$13.33M$14.63M2.57%+$1.30M
EyePoint, Inc.(EYPT)316,700628,367+311,667$2.98M$8.95M1.57%+$5.97M
Regeneron Pharmaceuticals, Inc.(REGN)10,67110,6710$5.60M$6.00M1.06%+$397.7K
Newamsterdam Pharma Company
ORDINARY SHARES
27,319194,838+167,519$494.7K$5.54M0.97%+$5.05M
Revolution Medicines, Inc.(RVMD)104,190104,1900$3.83M$4.87M0.86%+$1.03M
Avidity Biosciences Inc34,600110,100+75,500$982.6K$4.80M0.84%+$3.81M
Dianthus Therapeutics, Inc.(DNTH)0108,723+108,723$0$4.28M0.75%+$4.28M
Ionis Pharmaceuticals, Inc.(IONS)060,176+60,176$0$3.94M0.69%+$3.94M
Viking Therapeutics, Inc.(VKTX)96,479146,179+49,700$2.56M$3.84M0.68%+$1.28M
Scholar Rock Holding Corporation(SRRK)126,28596,285-30,000$4.47M$3.59M0.63%-$887.4K
AbbVie Inc.(ABBV)14,50014,5000$2.69M$3.36M0.59%+$665.8K
Nektar Therapeutics(NKTR)057,999+57,999$0$3.30M0.58%+$3.30M
Centessa Pharmaceuticals PlcADS0133,291+133,291$0$3.23M0.57%+$3.23M
Ascendis Pharma A/SADR(ASND)12,24012,2400$2.11M$2.43M0.43%+$320.8K
Mineralys Therapeutics, Inc.(MLYS)41,10056,600+15,500$556.1K$2.15M0.38%+$1.59M
United Therapeutics Corporation(UTHR)5,0005,0000$1.44M$2.10M0.37%+$659.3K
TG Therapeutics, Inc.(TGTX)54,51554,5150$1.96M$1.97M0.35%+$7.4K
Ultragenyx Pharmaceutical Inc.(RARE)41,83064,502+22,672$1.52M$1.94M0.34%+$419.3K
Rapport Therapeutics, Inc.(RAPP)064,608+64,608$0$1.92M0.34%+$1.92M
Ocular Therapeutix, Inc.(OCUL)0141,061+141,061$0$1.65M0.29%+$1.65M
Xenon Pharmaceuticals Inc.(XENE)40,00040,0000$1.25M$1.61M0.28%+$354.0K
Iren Limited
ORDINARY SHARES
033,200+33,200$0$1.56M0.27%+$1.56M
Protagonist Therapeutics Inc22,95122,9510$1.27M$1.52M0.27%+$256.1K
BrightSpring Health Services, Inc.(BTSG)041,600+41,600$0$1.23M0.22%+$1.23M
Biohaven Ltd.(BHVN)80,00080,0000$1.13M$1.20M0.21%+$72.0K
Kiniksa Pharmaceuticals International, plcCL A(KNSA)29,20029,2000$808.0K$1.13M0.20%+$325.9K
BridgeBio Pharma, Inc.(BBIO)020,400+20,400$0$1.06M0.19%+$1.06M
Mereo BioPharma Group plcADS(MREO)475,361475,3610$1.29M$979.2K0.17%-$309.0K
Sarepta Therapeutics, Inc.(SRPT)044,900+44,900$0$865.2K0.15%+$865.2K
Travere Therapeutics, Inc.(TVTX)30,90030,9000$457.3K$738.5K0.13%+$281.2K
Moderna, Inc.(MRNA)023,800+23,800$0$614.8K0.11%+$614.8K
Kalvista Pharmaceuticals Inc041,555+41,555$0$506.1K0.09%+$506.1K
Atyr Pharma Inc0372,276+372,276$0$268.6K0.05%+$268.6K
Alector Inc071,029+71,029$0$210.2K0.04%+$210.2K
Janux Therapeutics, Inc.(JANX)20,0000-20,000$462.0K$0—-$462.0K
Springworks Therapeutics Inc63,9300-63,930$3.00M$0—-$3.00M
Page 1 of 1
Artia Global Partners LP — 13F Holdings — Q3 2025 | TickerTrail